Stay updated with breaking news from Nasdaq Cers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cerus (NASDAQ:CERS – Get Rating) and Apyx Medical (NASDAQ:APYX – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Insider & Institutional Ownership 82.5% of Cerus shares are owned […]
Cerus Co. (NASDAQ:CERS – Get Rating) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 8,870,000 shares, an increase of 15.5% from the February 28th total of 7,680,000 shares. Based on an average daily trading volume, of 1,630,000 shares, the […]
Cerus (NASDAQ:CERS – Get Rating) and Artivion (NYSE:AORT – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations and institutional ownership. Profitability This table compares Cerus and Artivion’s net margins, return on […]
Cerus (NASDAQ:CERS – Get Rating) announced its earnings results on Thursday. The biotechnology company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.03, MarketWatch Earnings reports. Cerus had a negative net margin of 41.55% and a negative return on equity of 63.31%. During the same period in the previous year, […]
Cerus (NASDAQ:CERS – Get Rating) will be releasing its earnings data after the market closes on Thursday, May 5th. Analysts expect Cerus to post earnings of ($0.10) per share for the quarter. Cerus has set its FY 2022 guidance at EPS.Persons interested in registering for the company’s earnings conference call can do so using this […]